Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-07-13EMA Authorised: Libmyris (adalimumab) — Stada Arzneimittel AG
Authorised status for Libmyris (adalimumab) by Stada Arzneimittel AG for multiple inflammatory and autoimmune diseases.
-
EMA approval · 2026-07-13EMA Authorised: Idacio (adalimumab) — Fresenius Kabi Deutschland GmbH
European Medicines Agency authorises Idacio (adalimumab) for multiple inflammatory diseases, expanding the portfolio under Fresenius Kabi De…
-
CLINICAL_TRIALS trial_result · 2026-07-10Clinical Trial Results: A Study of Baricitinib in Participants With Rheumatoid Arthritis [Phase 4]
Phase 4 clinical trial results for baricitinib in rheumatoid arthritis have been completed and results posted.
-
EMA approval · 2026-07-01EMA Authorised: Gotenfia (golimumab) — Stada Arzneimittel AG
European Medicines Agency authorised Gotenfia (golimumab) by Stada Arzneimittel AG for multiple inflammatory diseases including various form…
-
EMA approval · 2026-07-01EMA Authorised: Erelzi (etanercept) — Sandoz GmbH
Authorised status for Erelzi (etanercept) by Sandoz GmbH, expanding access to therapy for multiple inflammatory arthritis conditions.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-06-24Clinical Trial Results: A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis [Phase 4]
Phase 4 trial results for baricitinib in rheumatoid arthritis have been completed with results posted.
-
EMA approval · 2026-06-15EMA Authorised: Tuyory — Chemical Works of Gedeon Richter Plc. (Gedeon Richter Plc.)
Tuyory has been authorised by the EMA for multiple indications including rheumatoid arthritis, juvenile arthritis, cytokine release syndrome…
-
EMA approval · 2026-06-12EMA Authorised: Fubelv — Biosimilar Collaborations Ireland Limited
EMA has authorised Fubelv as a biosimilar, with indications across various inflammatory arthritis and psoriasis conditions.
-
EMA approval · 2026-06-09EMA Authorised: Rinvoq (upadacitinib) — AbbVie Deutschland GmbH & Co. KG
EU authorization of Rinvoq (upadacitinib) by AbbVie Deutschland for multiple inflammatory indications including rheumatoid arthritis, psoria…
-
EMA approval · 2026-06-09EMA Authorised: Kineret (anakinra) — Swedish Orphan Biovitrum AB (publ)
New authorisation of Kineret (anakinra) for rheumatoid arthritis and COVID-19 infection in the EU.
-
EMA approval · 2026-06-09EMA Authorised: Avtozma (tocilizumab) — Celltrion Healthcare Hungary Kft.
Avtozma (tocilizumab) has been authorised in the EU for rheumatoid arthritis, juvenile idiopathic arthritis, cytokine release syndrome, and …
-
EMA approval · 2026-06-05EMA Authorised: Idacio (adalimumab) — Fresenius Kabi Deutschland GmbH
The EMA has authorised Idacio (adalimumab) by Fresenius Kabi Deutschland GmbH for multiple inflammatory diseases, marking a new approved pro…
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Results: Effects of Administration of SCFA in Rheumatoid Arthritis Inadequate Responders [NA]
Clinical trial results on the effects of short-chain fatty acid administration in rheumatoid arthritis patients who are inadequate responder…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Frequency and Complications of Major Orthopedic Procedures in Medicare Beneficiaries
A NIAMS-sponsored clinical trial update examines the frequency and complications of major orthopedic procedures among Medicare beneficiaries…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Study of Families With Twins or Siblings Discordant for Rheumatic Disorders
A completed clinical trial studying families with twins or siblings discordant for rheumatic disorders, conducted by NIEHS. The study includ…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014) [Phase 2]
A Phase 2 study of Tulisokibart (MK-7240) for rheumatoid arthritis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: The Effect of Cold Application in Patients With Rheumatoid Arthritis [NA]
A completed clinical trial evaluating the effect of cold application on pain and disease activity in patients with rheumatoid arthritis.
-
EMA approval · 2026-04-23EMA Authorised: Remsima (infliximab) — Celltrion Healthcare Hungary Kft.
EMA authorised Remsima (infliximab) from Celltrion Healthcare Hungary Kft. for multiple inflammatory diseases including rheumatoid arthritis…
-
EMA approval · 2026-04-23EMA Authorised: Amgevita (adalimumab) — Amgen Europe B.V.
EMA has authorised Amgevita (adalimumab) by Amgen Europe B.V., a biosimilar of adalimumab, for multiple inflammatory diseases including rheu…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: A Phase 3 Study to Evaluate Efficacy & Safety of Subcutaneous CT-P13 in Patients With Moderate to Severe Active Rheumatoid Arthritis [Phase 3]
Celltrion's Phase 3 trial evaluating subcutaneous CT-P13 for moderately to severely active rheumatoid arthritis has completed. The study ass…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis [Phase 2]
This clinical trial update describes a Phase 2 study evaluating the efficacy and safety of BGB-45035 versus placebo in adults with moderate …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY) [Phase 2]
Phase 2 trial START SYNERGY is evaluating multiple doses of ELV001 to treat active rheumatoid arthritis in patients with inadequate response…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis [Phase 2]
This is a clinical trial update for an adaptive Phase 2a/2b study of LY3871801 in adults with rheumatoid arthritis, with the trial currently…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis [Phase 2]
This update describes a Phase 2 clinical trial evaluating IMVT-1402 for efficacy, safety, and tolerability in adults with active, difficult-…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic Diseases [Phase 1]
Phase 1 clinical trial evaluating the safety of CD19-targeted CAR-T cell therapy produced at Gustave Roussy for adults with severe and refra…